FDA Regulatory Lawyer Gail Javitt Joins Epstein Becker Green

Washington, DC (July 31, 2017)Epstein Becker Green (EBG) is pleased to announce that it has added FDA regulatory lawyer Gail Javitt to its Washington, DC, office.  Ms. Javitt, who joins from DLA Piper, will be a Member of the Firm in EBG’s Health Care and Life Sciences practice.

Ms. Javitt provides strategic FDA regulatory advice for leading medical device, diagnostics, pharmaceutical, biological products, human cellular and tissue-based products (HCT/Ps), and dietary supplement companies throughout the product life cycle.  She has successfully resolved disputes for these types of entities both at the pre- and post-market stages.  She also has significant experience advising clinical laboratories on FDA and Clinical Laboratory Improvement Amendments (CLIA) requirements for laboratory developed tests.

In addition, Ms. Javitt has published and spoken widely on issues at the intersection of law and science, including FDA regulation of genetic testing, precision medicine, and next generation sequencing.  Earlier in her career, Ms. Javitt worked at the Genetics and Public Policy Center (part of John Hopkins University) in Washington, DC, as a law and policy director. In this role, she was responsible for developing policy options to guide the development and use of reproductive and other genetic technologies. Earlier in her legal career, Ms. Javitt clerked for the Honorable Gary Taylor of the U.S. District Court for the Central District of California.

“Gail’s extensive experience and thought leadership on the complex regulatory issues facing companies looking to innovate and comply with existing and emerging FDA regulations will add further depth to EBG’s existing capabilities in this space,” said George B. Breen, Chair of the firm’s National Health Care and Life Sciences Practice Steering Committee. “A number of leading companies have turned to Gail for her deep knowledge and skills, and we are thrilled to welcome her to our national team and look forward to the many contributions she will make here at EBG.”

Ms. Javitt’s academic experience has included serving as a faculty member at the Berman Institute of Bioethics at Johns Hopkins University and as an adjunct professor at the Georgetown University Law Center, American University’s Washington College of Law, and the University of Maryland School of Law. She was previously a Greenwall Fellow in Bioethics and Health Policy, a collaborative effort between Johns Hopkins University and Georgetown University. She earned her J.D. from Harvard Law School, her Master’s in Public Health from Johns Hopkins University, and her B.A. from Columbia College.

“Joining a firm known specifically for its intentional focus on the health care and life sciences industry is important to me because of the exceptional resources that the firm can offer its clients,” said Ms. Javitt. “Combining my experience with the firm’s talented bench is an exciting opportunity, and I look forward to the many collective successes we will achieve together.”

About Epstein Becker Green

Epstein Becker & Green, P.C., is a national law firm with a primary focus on health care and life sciences; employment, labor, and workforce management; and litigation and business disputes. Founded in 1973 as an industry-focused firm, Epstein Becker Green has decades of experience serving clients in health care, financial services, retail, hospitality, and technology, among other industries, representing entities from startups to Fortune 100 companies.  Operating in offices throughout the U.S. and supporting clients in the U.S. and abroad, the firm’s attorneys are committed to uncompromising client service and legal excellence.  For more information, visit www.ebglaw.com.